Exclusive

Publication

Byline

Location

Sun Pharma voluntarily recalls 11 eyedrops from domestic market, experts seek details

New Delhi, Aug. 3 -- Drugmaker Sun Pharmaceutical Industries has undertaken a voluntary recall of some of its ophthalmic products in the domestic market, with reports suggesting that 11 eyedrops were ... Read More


PE firm ChrysCapital acquires Swiss parent's stake in Novartis India

New Delhi, July 30 -- Private equity firm ChrysCapital has acquired a controlling 70.68 per cent stake in Novartis India Limited (NIL), previously held by the parent company, Swiss drugmaker Novartis ... Read More


RPGLS growth plans includes semaglutide launch and plant acquisition

New Delhi, July 29 -- In a challenging environment, RPG Life Sciences has had discussions with 13 of its international customers to help absorb escalating input costs, and that has reflected in its fi... Read More


A plant-source Vitamin D3 looks to light-up Fermenta Biotech's prospects

New Delhi, July 28 -- Vitamin D3 is required at all stages of life, "from the cradle to the grave," says Fermenta Biotech Managing Director Prashant Nagre, on the prospects that open-up for their plan... Read More


RG Kar violence and after: Unfinished task of keeping hospitals safe

New Delhi, July 27 -- A recent video showing a political representative in an altercation with medical staff, including seemingly raising his hand on a female doctor, at a hospital in Dombivli, near M... Read More


An outspoken doctor's reflective tale

New Delhi, July 26 -- The opening pages ofThe Liver Doctorreveal a thinking that may not quite sit with the confrontational online persona of its author Dr Cyriac Abby Philips. "From the time you are... Read More


US President Trump outlines tariff timeline for generic drugs shipped into the US

New Delhi, July 22 -- In the first time that generic drugs have been actively brought into the tariff conversation, US President Donald Trump has outlined a timeline for generic drugs, starting August... Read More


Pfizer confirms it had temporarily suspended its Premarin brand of vaginal cream in India

New Delhi, July 17 -- Multinational drugmaker Pfizer confirmed that it had suspended its Premarin brand of vaginal cream in India, adding that it was looking to restore supplies. "We wish to submit t... Read More


Oxford Vaccine Group launches world's first Phase I Bundibugyo ebolavirus vaccine trial

New Delhi, July 13 -- India's Serum Institute will provide doses for the world's first Phase I clinical trial for a vaccine against the Bundibugyo ebolavirus (BDBV) - being undertaken by the Oxford Un... Read More


The rush for GLP-1 weight-loss & diabetes drugs plateaus, says industry-tracker

New Delhi, July 8 -- After the race to launch generic semaglutide for weightloss and diabetes, the anti-diabetes market has stabilized, even as innovator drugs hold their own in this category, reveals... Read More